These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23672774)

  • 1. Commentary to 'Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis'.
    Chuang DC
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1064-5. PubMed ID: 23672774
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin injection of both sides of the face to treat post-paralytic facial synkinesis.
    Choi KH; Rho SH; Lee JM; Jeon JH; Park SY; Kim J
    J Plast Reconstr Aesthet Surg; 2013 Aug; 66(8):1058-63. PubMed ID: 23683725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Chundury RV; Perry JD
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70. PubMed ID: 26735958
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply re: "Treating Buccinator with Botulinum Toxin in Patients with Facial Synkinesis: A Previously Overlooked Target".
    Lucarelli MJ; Wei LA; Diels J
    Ophthalmic Plast Reconstr Surg; 2016; 32(1):70-1. PubMed ID: 26735959
    [No Abstract]   [Full Text] [Related]  

  • 5. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation and treatment of synkinesis with botulinum toxin following facial nerve palsy.
    Toffola ED; Furini F; Redaelli C; Prestifilippo E; Bejor M
    Disabil Rehabil; 2010; 32(17):1414-8. PubMed ID: 20156046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term therapy with botulinum toxin in facial synkinesis: Retrospective data analysis of data from 1998 to 2018.
    Alipour S; Pick C; Jansen S; Rink S; Klußmann JP; Grosheva M
    Clin Otolaryngol; 2021 Jul; 46(4):758-766. PubMed ID: 33534183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum Toxin in Facial Reanimation: Map of the Facial Musculature and Dosage.
    VandeWater T; Hetzler L
    Atlas Oral Maxillofac Surg Clin North Am; 2023 Mar; 31(1):71-83. PubMed ID: 36754509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.
    Shinn JR; Nwabueze NN; Du L; Patel PN; Motamedi KK; Norton C; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2019 May; 21(3):244-251. PubMed ID: 30703206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced functional oculofacial indications of botulinum toxin.
    Lee C; Kikkawa DO; Pasco NY; Granet DB
    Int Ophthalmol Clin; 2005; 45(3):77-91. PubMed ID: 15970767
    [No Abstract]   [Full Text] [Related]  

  • 11. Botulinum Toxin Type A Injection in the Treatment of Postparetic Facial Synkinesis: An Integrative Review.
    Tavares H; Oliveira M; Costa R; Amorim H
    Am J Phys Med Rehabil; 2022 Mar; 101(3):284-293. PubMed ID: 35175961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Changes in the Treatment Pattern of Botulinum Toxin A Injections for Postfacial Paralysis Synkinesis Following Modified Selective Neurectomy.
    Hjelm N; Crippen M; Azizzadeh B
    Facial Plast Surg Aesthet Med; 2021; 23(3):234-235. PubMed ID: 33306003
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of blepharospasm, hemifacial spasm and facial synkinesis with botulinum toxin].
    Winterhoff J; Laskawi R
    HNO; 2012 Jun; 60(6):479-83. PubMed ID: 22669435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted chemodenervation of the posterior belly of the digastric muscle for the management of jaw discomfort in facial synkinesis.
    Pescarini E; Butler DP; Perusseau-Lambert A; Nduka C; Kannan RY
    J Plast Reconstr Aesthet Surg; 2021 Dec; 74(12):3437-3442. PubMed ID: 34233854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of pseudoptosis secondary to aberrant regeneration of the facial nerve with botulinum toxin type A.
    McElhinny ER; Reich I; Burt B; Mancini R; Wladis EJ; Durairaj VD; Shinder R
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):175-8. PubMed ID: 23467287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 3 Commercially Available Botulinum Toxin Neuromodulators on Facial Synkinesis: A Randomized Clinical Trial.
    Thomas AJ; Larson MO; Braden S; Cannon RB; Ward PD
    JAMA Facial Plast Surg; 2018 Mar; 20(2):141-147. PubMed ID: 28973094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic Overview of Synkinesis in 353 Patients with Longstanding Facial Paralysis under Treatment with Botulinum Toxin for 11 Years.
    Salles AG; da Costa EF; Ferreira MC; do Nascimento Remigio AF; Moraes LB; Gemperli R
    Plast Reconstr Surg; 2015 Dec; 136(6):1289-1298. PubMed ID: 26595022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buccinator synkinesis treated by botulinum toxin in facial palsy and hemifacial spasms.
    Kanerva M
    J Plast Reconstr Aesthet Surg; 2021 Jul; 74(7):1464-1469. PubMed ID: 33358465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.